¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"immunological surveillance theory"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® immunological reaction ÇÑ±Û ¸é¿ª¹ÝÀÀ
¼³¸í   
  »ýüÀÇ ¸ö ¾È¿¡¼­ »ý±ä ¹°ÁúÀ̳ª ¸ö ¹Û¿¡¼­ µé¾î¿Â ¹°ÁúÀÌ »ýü¿Í ´Ù¸¦ ¶§ ÀÚ±â Ã¼³»ÀÇ ÅëÀϼº°ú °³Ã¼ÀÇ »ýÁ¸ À¯Áö ¹× Á¾ÀÇ Á¸¼ÓÀ» À§ÇÏ¿© ±× ¹°ÁúµéÀ» Á¦°ÅÇϴ ÀÏ·ÃÀÇ »ýü ¹ÝÀÀ. ´Ù½Ã ¸»ÇØ B¼¼Æ÷¿¡ ÀÇÇÑ Ç×ü»ý»ê, T¼¼Æ÷¸¦ Áß½ÉÀ¸·Î Çϴ ¼¼Æ÷¼º ¸é¿ª, ¸é¿ª°ü¿ë, ¸é¿ª±â¾ï µîÀÇ »ýü ³» ¹ÝÀÀÀ» ¸»ÇÑ´Ù. Å«Æ÷½Ä¼¼Æ÷´Â Ç׿øÀ» Ã³¸®Çؼ­ Æ¯ÀÌÀûÀΠÇ׿ø°áÁ¤±â¸¦ °®´Â ºÐÀڷΠ¹Ù²ã, Ç׿ø°ú ÁÖ¿äÁ¶Á÷ ÀûÇÕÀ¯ÀüÀÚº¹ÇÕü¸¦ ¼¼Æ÷Ç¥¸é¿¡ Ç¥ÇöÇϸç, T¼¼Æ÷·Î Àü´ÞÇÑ´Ù. ÇÑÆí B¼¼Æ÷´Â Å«Æ÷½Ä¼¼Æ÷ ³»¿¡¼­ Ã³¸®µÈ Ç׿øÀÇ °áÁ¤±â¸¦ ÀνÄÇÏ¿© ´ëÀÀÇϴ ƯÀÌÀûÇ×ü¸¦ »ý»êÇÏ¿© Ç׿øÀ» Ã³¸®ÇÑ´Ù. 
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunological surveillance
    ¸é¿ª°¨½Ã
  • epidemiological surveillance
    ¿ªÇа¨½Ã
  • immune surveillance
    ¸é¿ª°¨½Ã
  • infection control surveillance
    °¨¿°°ü¸®°¨½Ã
  • post-marketing surveillance
    ½ÃÆÇÈĺÎÀÛ¿ë°¨½Ã
  • surveillance
    °¨½Ã, °¨µ¶
  • immunological
    ¸é¿ªÇÐÀû-
  • immunological adjuvant
    ¸é¿ªº¸°­Á¦
  • immunological disease
    ¸é¿ªº´, ¸é¿ªÁúȯ
  • immunological incompetence
    ¸é¿ªºÎÀü
  • immunological recognition
    ¸é¿ªÀνÄ
  • immunological unresponsiveness
    ¸é¿ª¹«¹ÝÀÀ
  • clonal selection theory
    Ŭ·Ð¼±Åü³
  • convergence-projection theory
    ÆøÁÖÅõ»ç¼³, ´«¸ðÀ½Åõ»ç¼³
  • corpuscular theory
    ÀÔÀÚ¼³
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • surveillance
    °¨½Ã
  • theory
    Çм³, ¼³, ÀÌ·Ð
  • multiple causation theory
    Áúº´¹ß»ý´Ù¿äÀμ³
  • psychoanalytic theory
    Á¤½ÅºÐ¼®ÀÌ·Ð
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunological surveillance
    ¸é¿ª°¨½Ã
  • surveillance data
    °ü¸®Á¤º¸Á¶»çÀÚ·á
  • epidemiological surveillance
    ¿ªÇа¨½Ã,
  • immune surveillance
    ¸é¿ª°¨½Ã
  • infection control surveillance
    °¨¿°°ü¸®°¨½Ã
  • post-marketing surveillance
    ½ÃÆÇÈĺÎÀÛ¿ëÁ¶»ç
  • surveillance
    °¨½Ã
  • surveillance
    ¿ªÇаü¸®Á¤º¸Á¶»ç
  • immunological absorbent
    ¸é¿ªÈíÂøÁ¦
  • immunological adjuvant
    ¸é¿ªº¸°­Á¦
  • immunological competence
    ¸é¿ªÀû°Ý¼º
  • immunological disease
    ¸é¿ªÁúȯ
  • immunological
    ¸é¿ªÇÐÀû-
  • immunological incompetence
    ¸é¿ªºÎÀü
  • immunological reaction
    (¢¡immune) ¸é¿ª¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunological surveillance
    ¸é¿ª°¨½Ã(±â±¸)(ÊÙ˧Ëà˻˴), ¸é¿ªÁ¶»ç.
  • immunological surveillance
    ¸é¿ª°¨½Ã(±â±¸)(¡­ÊøãÊѦϰ), ¸é¿ªÁ¶»ç.
  • PMS : post marketing surveillance
    ½ÃÆÇÈÄ ºÎÀÛ¿ëÁ¶»ç.
  • immune surveillance
    ¸é¿ª°¨½Ã
  • immune surveillance
    ¸é¿ª[ÇÐÀû]°¨½Ã±âÀü
  • immunologic surveillance
    ¸é¿ª°¨½Ã(±â±¸).
  • infection control surveillance
    °¨¿°°ü¸®°¨½Ã
  • post marketing surveillance
    ½ÃÆÇÈÄ ºÎÀÛ¿ëÁ¶»ç
  • Frequency theory of hearing
    û°¢(ôéÊÆ)ÀÇ Áøµ¿¼ö(òÉÔÑâ¦) Çм³(ùÊàã)
  • Young-Helmholtz theory
    ¿µ-Ç︧ȦÃ÷ ¼³
  • adsorption theory
    ÈíÂø¼³, Èí¼ö¼³.
  • aging,free radical theory
    À¯¸®±â ¼³(ë´×îÐñàã)
  • alternation theory
    ±³¹ø¼³(ÎßÛãæò).
  • gate control theory
    (°ü)¹®Á¶Àý¼³(μڦðàï½àã).
  • general system theory
    ÀϹÝü°è(ÀÌ)·Ð(ìéÚõô÷ͧìµÖå)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunological surveillance
    ¸é¿ª°¨½Ã(±â±¸)(¡­ÊøãÊѦϰ), ¸é¿ªÁ¶»ç.
  • immunological surveillance
    ¸é¿ª°¨½Ã(±â±¸)(ÊÙ˧Ëà˻˴), ¸é¿ªÁ¶»ç.
  • epidemiological surveillance
    ¿ªÇÐÀû °¨½Ã(ËçÌ°ËøË§Ëà), ¿ªÇÐÀû °ü¸®Á¤º¸Á¶ »ç.
  • immune surveillance
    ¸é¿ª[ÇÐÀû]°¨½Ã±âÀü
  • immune surveillance
    ¸é¿ª°¨½Ã
  • immunologic surveillance
    ¸é¿ª°¨½Ã(±â±¸).
  • infection control surveillance
    °¨¿°°ü¸®°¨½Ã
  • post marketing surveillance
    ½ÃÆÇÈÄ ºÎÀÛ¿ëÁ¶»ç
  • surveillance
    °ü¸®Á¤º¸Á¶»ç(Ë´ËöËøËÓÌ¡Ë×), °¨½Ã±â±¸(˧Ëà˻˴).
  • surveillance data
    °ü¸®Á¤º¸Á¶»çÀÚ·á
  • competence, immunological
    ¸é¿ªÀû°Ý¼º
  • enhancement, immunological
    ¸é¿ªÁõ°­Çö»ó
  • immunological
    ¸é¿ªÇÐÀû.
  • immunological
    ¸é¿ªÇÐÀû.
  • immunological absorbent
    ¸é¿ªÈíÂøÁ¦.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunological surveillance theory
    ¸é¿ª °¨½Ã ÀÌ·Ð(Øóæ¹ÊøãÊ×âÖå)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immune surveillance theory
    ¸é¿ª °¨½Ã ÀÌ·Ð(Øóæ¹ÊøãÊ×âÖå)
  • immunological competence
    ¸é¿ª´É(Øóæ¹Òö)
  • immunological enhancement
    ¸é¿ª Áõ°­(Øóæ¹ñòË­)
  • immunological equivalence
    ¸é¿ª ´ç·®(Øóæ¹Ó×Õá)
  • immunological inhibition
    ¸é¿ª ÀúÇØ(Øóæ¹îÁúª)
  • immunological paralysis
    ¸é¿ª ¸¶ºñ(Øóæ¹Ø«Ýö)
  • immunological rejection
    ¸é¿ª °ÅºÎ(Øóæ¹ËÞÜú)
  • immunological suppression
    ¸é¿ª ¾ï¾Ð(Øóæ¹åääâ)
  • immunological tolerance
    ¸é¿ª ³»¼º(Øóæ¹Ò±àõ)
  • immunological unresponsiveness
    ¸é¿ª ¹«´ëÀÀ(Øóæ¹ÙíÓßëë)
  • accumulation theory
    ´©Àû·Ð (ÒéîÝÖå)
  • active aldehyde theory
    Ȱ¼º(üÀàõ)¾Ëµ¥ÇÏÀ̵å·Ð(Öå)
  • Bronsted-Lowry theory
    ºê·Ð½ºÅ×µå Ã˸ŷÐ(õºØÚÖå)
  • Burnet's theory
    ¹ö³Ý ·Ð(Öå)
  • Busch theory
    ºÎ½¬ ·Ð(Öå)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • theory
    ¼³, ÀÌ·Ð
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SDT sensory detection theory; right sacrotransverse [fetal position] [Lat. sacrodextra transversa]; sign...
IT immunological test; immunotherapy; implantation test; individual therapy; information technology; in...
DOI date of injury; died of injuries; diffusion of innovations [theory]
MAUT multi-attribute utility theory
theor theory, theoretical
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
R.I.A. radio-immunological assay
DFT Density Functional Theory
IRT Item Response Theory
SDT Signal Detection Theory
TOM Theory of Mind
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • epidemiological surveillance
    ¿ªÇÐÀû °¨½Ã
  • immunological
    ¸é¿ªÇÐÀû
    ¸é¿ªÇп¡ °üÇÑ.
  • immunological deficiency state
    ¸é¿ª °áÇÌ »óÅÂ
  • immunological enhancement
    ¸é¿ª Áõ°­ Çö»ó, ¸é¿ª Áõ°­
    ¸é¿ª ¹ÝÀÀÀÇ ¼öÁØÀ» Áõ´ë½ÃŰ´Â ¿©·¯ °¡Áö ƯÀÌÀû ¶Ç´Â ºñƯÀÌÀû »óȲ.
  • immunological incompetence
    ¸é¿ª ºÎÀü
  • immunological paralysis
    ¸é¿ª ¸¶ºñ, ¸é¿ª °ü¿ë
    ´Ù·®ÀÇ Ç׿ø Åõ¿©¿¡ ÀÇÇÏ¿© ¸é¿ªÇÐÀû ¹ÝÀÀÀÌ ¼Ò½ÇµÈ »óÅÂ.
  • immunological resistance
    ¸é¿ª ÀúÇ×
  • immunological tolerance
    ¸é¿ª ³»¼º
    ´Ù¸¥ »óÅ¿¡¼­´Â ü¾×¼º ¶Ç´Â ¼¼Æ÷ ¸Å°³ ¸é¿ªÀ» À¯¹ßÇÒ ¼ö Àִ ƯÁ¤ÀÇ Ç׿ø¿¡ ´ëÇØ¼­, ¸²ÇÁ°è Á¶Á÷ÀÇ Æ¯ÀÌÀû ¹«¹ÝÀÀ¼ºÀÌ ÀϾµµ·Ï µÇ´Â °ÍÀ» Ư¡ÀûÀ¸·Î ÇÏ´Â ¸é¿ª ¹ÝÀÀ.
  • acid decalcification theory
    Żȸ¼³
    ¿ì½ÄÀÇ º´Àο¡ °üÇÑ ¼³·Î ¼¼±ÕÀ» »ý»êÇÏ´Â »ê ȤÀº ´çºÐÀ» Æ÷ÇÔÇÑ À½½Ä¹°ÀÇ Àܻ翡 ¹ßÈ¿¿¡ ÀÇÇÏ¿© »ý±ä »êÀÌ Ä¡ÁúÀ» ŻȸÇÏ¿© ¿ì½ÄÀÌ »ý±ä´Ù´Â ¼³.
  • acidogenic theory
    »êÀηÐ, »ê»ý¼º ÀÌ·Ð, È­ÇÐ ¼¼±Õ¼³
    Ä¡¾Æ ¿ì½ÄÀº chemico-
  • aging,free radical theory
    À¯¸®±â¼³
  • alternation theory
    ±³¹ø¼³
  • apposition theory
    ºÎÂø¼³
  • biophysical theory
    »ý¹°¸®Çм³
  • Burnet's clonal selection theory
    ?
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
immunological surveillance <immunology> The hypothesis that lymphocyte traffic ensures that all or nearly all parts of the vertebrate body are surveyed by visiting lymphocytes in order to detect any altered self material, for example mutant cells.
(18 Nov 1997)
cancer, colon: screening and surveillance Colon cancer is both preventable and curable. It is preventable by removing precancerous colon polyps. It is curable if early cancer is surgically removed before cancer spread to other parts of the body. Therefore, if screening and surveillance programs were practiced universally, there would be a major reduction in the incidence and mortality of colon cancer.
(12 Dec 1998)
population surveillance <epidemiology> Ongoing scrutiny of a population (general population, study population, target population, etc.), generally using methods distinguished by their practicability, uniformity, and frequently their rapidity, rather than by complete accuracy.
(12 Dec 1998)
post-marketing surveillance Procedure implemented after a drug has been licensed for public use, designed to provide information on use and on occurrence of side effects, adverse effects, etc.
(05 Mar 2000)
product surveillance, postmarketing Surveillance of drugs, devices, appliances, etc., for efficacy or adverse effects, after they have been released for general sale.
(12 Dec 1998)
sentinel surveillance Monitoring of rate of occurrence of specific conditions to assess the stability or change in health levels of a population. It is also the study of disease rates in a specific cohort, geographic area, population subgroup, etc. To estimate trends in larger population.
(12 Dec 1998)
surveillance Oversight; watch; inspection; supervision. "That sort of surveillance of which . . . The young have accused the old." (Sir W. Scott)
Origin: F, fr. Surveiller to watch over; sur over + veiller to watch, L. Vigilare. See Sur-, and Vigil.
Source: Websters Dictionary
(01 Mar 1998)
immune surveillance <immunology> The hypothesis that lymphocyte traffic ensures that all or nearly all parts of the vertebrate body are surveyed by visiting lymphocytes in order to detect any altered self material, for example mutant cells.
(18 Nov 1997)
immunologic surveillance The theory that T-cells monitor cell surfaces and detect structural changes in the plasma membrane and/or surface antigens of virally or neoplastically transformed cells.
(12 Dec 1998)
models, immunological Theoretical representations that simulate the behaviour or activity of immune system, processes, or phenomena. They include the use of mathematical equations, computers, and other electrical equipment.
(12 Dec 1998)
immunological Pertaining to immunology.
(18 Nov 1997)
immunological competence <immunology> The bodys ability to develop an immune response to infection or disease. Immunocompetence is measured to see how well the body can fight off certain disease. Many cancer patients become immunocompromised, where their immune system is not as strong as a healthy person's.
(16 Dec 1997)
immunological deficiency Inabillity to mount a normal immune response. Immunodeficiency can be due to a genetic disease or acquired as in aids due to HIV.
(12 Dec 1998)
immunological disease <immunology> Any illness, such as an allergy, that is caused by the action of antibodies.
(09 Oct 1997)
immunological enhancement In immunology, the potentiating effect of specific antibody in establishing and in delaying rejection of a tumour allograft; aside from antibody, non-specific substances may also act to enhance immune response.
Synonym: immunological enhancement.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • surveillance
    °¨½Ã; °¨µ¶
  • electronic surveillance
    ÀüÀÚ °¨½Ã(Á¤º¸ ¼öÁý)
  • immune surveillance
    IMMUNOLOGICAL SURVEILLANCE
  • surveillance
    °¨½Ã;°¨µ¶;under ~ °¨µ¶À» ¹Þ°í
  • theory
    ÀÌ·Ð,-¼³,Àǰß
  • Development theory
    (»ý)(¶ó¸¶¸£Å©ÀÇ)ÁøÈ­·Ð
  • Dow theory
    ´Ù¿ì ÀÌ·Ð(½ÃÀåÀÇ °¡°Ý º¯µ¿¿¡ ÀÔ°¢ÇÑ Áõ±Ç ½Ã¼¼ÀÇ ¿¹»ó¹ý)
  • Einstein theory
    ¾ÆÀν¶Å¸ÀÎÀÇ »ó´ë¼º ¿ø¸®
  • atomic theory
    ¿øÀÚ·Ð
  • atonic theory
    ¿øÀÚ·Ð
  • big bang theory
    ¿ìÁÖ°¡ Æø¹ß¿¡ ÀÇÇÏ¿© »ý¼ºÇÏ°í ÆØÃ¢;¼öÃàÀ» µÇÇ®ÀÌÇÑ´Ù´Â ¼³
  • communication(s) theory
    Á¤º¸ÀÌ·Ð
  • corpuscular theory
    ÀÔÀÚ¼³
  • desk theory
    ʻ󰸷Ð
  • diluvial theory
    (ÁöÁú)È«¼ö¼³(³ë¾ÆÀÇ È«¼ö¸¦ Áö±¸ ¿ª»ç»ó ÃÖ´ëÀÇ »ç½Ç·Î º¸¸ç È­¼®À» È«¼ö·Î »ç¸êÇÑ »ý¹°ÀÇ À¯Ã¼·Î º½)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á